Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Sofia Palma, Jin‐Gun Cho, Varvara Solodovnikova(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Marcos Abdo Arbex(Fundação Araucária), Israel Fernandez, Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Ana Garavagno, Carolina Taiba, Marcelo Fouad Rabahi, Eduardo Muñóz(Instituto Maimónides de Investigación Biomédica de Córdoba), Nicolás Casco, Justin T. Denholm, Domingo Palmero(Hospital Muñiz), Wafaa Ezz, Martina Hartwig Bahamondes, Macarena Espinoza Revillot, Rolando Pizarro, Greg J. Fox(The University of Sydney), Patricia Gallegos Tapia, Ximena Figueroa Flores, Muntasir Saffie, Joaquín Farías Valdés, Denise Rossato Silva, Roberta Sales, Jorge Navarro Subiabre, Ana María Pradenas, Tatiana Alves, Giovana Rodrigues Pereira, Nadia Escobar Salinas(Ministry of Health), Ruth Caamaño Miranda, Alberto Levi Jorge, Catalina Cisterna, Carolina Guajardo Vera, Monica Carbonell, Angeles Serrano Salinas, Camila Muñoz, Patricia Rodríguez, L. Merino, Clorinda Concha, Maria Soledad Vergara Riquelme, Claudia Villalón, Viviana Cancino, Indira Navarro, Gloria Pereira Cristina Sánchez, Carlos Ortega, Evelyn Vilca, Aline Soto, Jan‐Willem C. Alffenaar(The University of Sydney), Arturo Jiménez Cruz
Cited by 33
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688